Ekso Bionics Holdings Files 8-K on Shareholder Votes
Ticker: EKSO · Form: 8-K · Filed: Jun 10, 2024 · CIK: 1549084
| Field | Detail |
|---|---|
| Company | Ekso Bionics Holdings, Inc. (EKSO) |
| Form Type | 8-K |
| Filed Date | Jun 10, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-vote, corporate-governance
Related Tickers: EKSO
TL;DR
EKSO filed an 8-K on shareholder votes, check for details on governance changes.
AI Summary
Ekso Bionics Holdings, Inc. filed an 8-K on June 10, 2024, reporting on matters submitted to a vote of security holders. The filing date indicates the report was prepared as of June 10, 2024, with the earliest event reported on June 6, 2024. The company, incorporated in Nevada, is involved in general industrial machinery and equipment.
Why It Matters
This filing informs shareholders about important decisions and votes that could impact the company's governance and future direction.
Risk Assessment
Risk Level: low — This is a routine filing reporting on shareholder votes, not indicating immediate financial distress or significant operational changes.
Key Players & Entities
- Ekso Bionics Holdings, Inc. (company) — Registrant
- Nevada (jurisdiction) — State of incorporation
- June 6, 2024 (date) — Date of earliest event reported
- June 10, 2024 (date) — Date of report
FAQ
What specific matters were submitted to a vote of security holders?
The filing indicates that matters were submitted to a vote of security holders, but the specific details of these matters are not provided in the excerpt.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on June 6, 2024.
What is the principal executive office address for Ekso Bionics Holdings, Inc.?
The principal executive office is located at 101 Glacier Point, Suite A, San Rafael, California 94901.
In which state was Ekso Bionics Holdings, Inc. incorporated?
Ekso Bionics Holdings, Inc. was incorporated in Nevada.
What is the SIC code for Ekso Bionics Holdings, Inc.?
The Standard Industrial Classification (SIC) code for Ekso Bionics Holdings, Inc. is 3569, which corresponds to General Industrial Machinery & Equipment, NEC.
Filing Stats: 969 words · 4 min read · ~3 pages · Grade level 12 · Accepted 2024-06-10 17:28:29
Key Financial Figures
- $0.001 — ge on which registered Common Stock , $0.001 par value per share EKSO NASDAQ Capit
Filing Documents
- ekso20240610_8k.htm (8-K) — 48KB
- 0001437749-24-019834.txt ( ) — 179KB
- ekso-20240606.xsd (EX-101.SCH) — 3KB
- ekso-20240606_def.xml (EX-101.DEF) — 11KB
- ekso-20240606_lab.xml (EX-101.LAB) — 15KB
- ekso-20240606_pre.xml (EX-101.PRE) — 11KB
- ekso20240610_8k_htm.xml (XML) — 3KB
07. Submission of Matters to a Vote of Security Holders
Item 5.07. Submission of Matters to a Vote of Security Holders. On June 6, 2024, Ekso Bionics Holdings, Inc. (the "Company") held its 2024 Annual Meeting of Stockholders (the "Annual Meeting"). Of the 18,099,260 shares of common stock outstanding and entitled to vote at the Annual Meeting, 11,425,241 shares were present at the Annual Meeting either virtually or by proxy, constituting a quorum. The stockholders voted on the following proposals at the Annual Meeting: 1. To elect five persons to the Company's board of directors, to serve until the annual meeting of stockholders to be held in 2025 and until their respective successors are elected and qualified, or until their earlier death, resignation or removal; 2. To approve the extension of the term of the Company's Amended and Restated 2014 Equity Incentive Plan until April 15, 2034 and to establish the total number of shares of common stock authorized for issuance pursuant to awards granted thereunder to 4,724,286 (an increase in the total number of shares of common stock authorized for issuance pursuant to awards of 1,000,000 as compared to the prior total number of shares of common stock authorized for issuance pursuant to awards under the Company's Amended and Restated 2014 Equity Incentive Plan prior to its expiration); 3. To approve, in an advisory (non-binding) vote, the compensation of the Company's named executive officers; 4. To approve, in an advisory (non-binding) vote, the frequency of future stockholder advisory votes on the compensation of our named executive officers; and 5. To ratify the appointment of WithumSmith+Brown, PC as the Company's independent auditors for the year ending December 31, 2024. For more information about the foregoing proposals, see the Company's proxy statement, filed with the Securities and Exchange Commission on April 26, 2024. The voting results for each of the proposals are as follows: 1. Election of Directors Nominee For Withheld Broker Non-vot